tirzepatide health canada approval Mounjaro Now Available in Clinical trial on GLP-1RA (tirzepatide)

38.7%) and suicidal ideation (n = 73

Results were presented by Deborah B Horn, DO, MPH, medical director of the UT Physicians Center for Obesity Medicine and Metabolic Performance and clinical assistant professor at McGovern Medical School at The University of Texas Health Science Center at Houston (UTHealth), and Carel W le Roux, MBChB, MSC, FRCP, FRCPath, PhD, director of the Metabolic Medicine Group and Professor of Metabolic Medicine at Ulster University

Others prefer evening injections to sleep through peak side effect periods

Late responders had lost less than 5 percent but, crucially, 90 percent of them went on to achieve 5 percent or greater weight loss by week 72

Awesome impact

Some providers start patients on a lower concentration for the first month, then switch to 20mg/mL as doses increase